Last checked at 15 Dec 2023 17:08
European shares end fifth week higher on rate-cut optimism
Barclays sees first ECB rate cut in April
*Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades6,138
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,653.00
Bid:
1,654.00
Ask:
1,654.50
Change:
12.50 (0.76%)
Spread:
0.50 (0.03%)
Open:
1,638.50
High:
1,655.50
Low:
1,634.00
Prev. Close:
1,640.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.FTSE 100 movers: StanChart slides after third-quarter results disappoint
Tue, 28th Oct 2014 14:46
Shares in banking group Standard Chartered dropped after the company reported a 16% decline in operating profit in the third quarter and said that full-year earnings would be lower than last year.Shares in banking counterpart Standard Chartered dropped after the company reported a 16% decline in operating profit in the third quarter and said that full-year earnings would be lower than last year.Underlying profits were higher than expected at Lloyds Banking Group, rising 44% year-on-year in the third quarter, but shares fell as analysts raised concerns about further PPI impairment charges and the outlook for the UK housing market.Lower prices and higher costs led to a worse-than-expected 26% drop in adjusted profits at BG Group in the third quarter despite higher revenues, pushing the stock lower.Jefferies International dragged GlaxoSmithKline after cutting its target price from 1,400p to 1,350p.Meanwhile, the upside was led by the mining sector, with Anglo American, Glencore, BHP Billiton and Rio Tinto among the best performers, thanks in part to a jump in copper prices.BP reported that profits fell by almost a fifth in the third quarter, but the stock moved higher after the oil major still beat the market's expectations and said it was "well on track" to hit its targets this year. FTSE 100 - RisersAnglo American (AAL) 1,339.50p +3.32%Aberdeen Asset Management (ADN) 412.30p +2.84%Dixons Carphone (DC.) 389.60p +2.77%Smith & Nephew (SN.) 1,005.00p +2.76%Antofagasta (ANTO) 697.00p +2.73%St James's Place (STJ) 691.50p +2.52%Royal Mail (RMG) 453.80p +2.25%Mondi (MNDI) 1,009.00p +2.23%Aviva (AV.) 517.00p +2.17%Glencore (GLEN) 319.15p +2.08%FTSE 100 - FallersStandard Chartered (STAN) 1,006.50p -8.08%Lloyds Banking Group (LLOY) 74.00p -1.78%BG Group (BG.) 1,025.50p -1.68%Burberry Group (BRBY) 1,485.00p -0.93%GlaxoSmithKline (GSK) 1,386.00p -0.93%InterContinental Hotels Group (IHG) 2,256.00p -0.53%Aggreko (AGK) 1,494.00p -0.33%Royal Bank of Scotland Group (RBS) 358.20p -0.28%IMI (IMI) 1,174.00p -0.17%Whitbread (WTB) 4,329.00p -0.14%
More News
15 Dec 2023 16:51
LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools
(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.
Read more15 Dec 2023 16:29
PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg
(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.
Read more12 Dec 2023 10:08
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal
Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.
Read more12 Dec 2023 08:22
TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine
(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.
Read more12 Dec 2023 07:39
LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI
(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.
Read more12 Dec 2023 07:24
GSK seeks to extend RSV vaccine approval in Japan
(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.
Read more11 Dec 2023 08:28
GSK drug gets EU marketing backing for form of endometrial cancer
(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.
Read more11 Dec 2023 07:41
LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook
(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.
Read more11 Dec 2023 07:23
GSK endometrial cancer treatment gets Europe authorisation
(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.
Read more7 Dec 2023 12:54
THG backer Kelso pushes for demerger to trim "inherent" valuation gap
(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.
Read more5 Dec 2023 10:02
LONDON BROKER RATINGS: Goldman lifts Landsec and British Land
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
Read more27 Nov 2023 09:00
GSK announces positive results from Blenrep phase 3 blood cancer trial
(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.
Read more27 Nov 2023 08:02
GSK receives 'positive' headline results from phase III trial
(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.
Read more22 Nov 2023 09:48
LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Read more